Literature DB >> 2466899

Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1).

T F Tedder1, G Klejman, S F Schlossman, H Saito.   

Abstract

The CD20 (B1) molecule is a differentiation Ag found only on the surface of B lymphocytes. This structurally unique phosphoprotein plays a role in the regulation of human B cell proliferation and differentiation. In this report genomic DNA clones containing the human CD20 gene were isolated and the structure of the CD20 gene determined. Southern blot analysis revealed that CD20 mRNA was transcribed from a single-copy gene. The CD20 gene was 16 kb long and was composed of eight exons. The first exon marked the major transcription initiation site as determined by primer extension and S1 nuclease analysis. The translation initiation codon was located within the third exon. Exon VIII encoded the COOH terminus of the CD20 protein and the long 3' untranslated region. Three forms of CD20 mRNA were identified that all encode an identical protein product. The dominant form of 2.8 kb results from usage of exons I through VIII, whereas a second form that is 263 bp shorter had exon I spliced into an internal 3' splice site within exon III thereby skipping exon II. A minor 3.4-kb mRNA species most likely results from an uncharacterized upstream exon(s) splicing into an internal 3' slice site located in exon I. Nucleotide sequences of cDNA clones representative of each of these RNA forms are presented. The 5' splice site following exon V was found to be divergent from the consensus splice sequence. A relationship between the individual peptides encoded by the six exons and structurally distinct regions of the CD20 protein is likely.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466899

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes.

Authors:  L J Zhou; D C Ord; S A Omori; T F Tedder
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

Review 3.  The MS4A family: counting past 1, 2 and 3.

Authors:  Li Eon Kuek; Melanie Leffler; Graham A Mackay; Mark D Hulett
Journal:  Immunol Cell Biol       Date:  2015-04-03       Impact factor: 5.126

4.  Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen.

Authors:  D Y Mason; W M Comans-Bitter; J L Cordell; M A Verhoeven; J J van Dongen
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

5.  A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.

Authors:  C Berger; M Berger; D Anderson; S R Riddell
Journal:  J Med Primatol       Date:  2010-11-02       Impact factor: 0.667

Review 6.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

Review 7.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

8.  Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma.

Authors:  Noriyasu Hashida; Nobuyuki Ohguro; Kohji Nishida
Journal:  Transl Vis Sci Technol       Date:  2012-10-22       Impact factor: 3.283

9.  Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48).

Authors:  R C Fisher; D A Thorley-Lawson
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  MS4a4B, a CD20 homologue in T cells, inhibits T cell propagation by modulation of cell cycle.

Authors:  Hui Xu; Yaping Yan; Mark S Williams; Gregory B Carey; Jingxian Yang; Hongmei Li; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.